Pulmonary embolism management restructures around catheter-directed therapy and risk stratification

Pulmonary embolism (PE) management has been an anticoagulation, systemic thrombolysis in massive PE, and surgical embolectomy in selected cases category. DOAC first-line for most acute PE is now established, catheter-directed thrombolysis and mechanical thrombectomy are widening for intermediate-high-risk PE, and structured pulmonary embolism response team (PERT) infrastructure is formalising care delivery. The risk-stratification pathway (right ventricular function, biomarkers, clinical features) defines acute treatment intensity.